Literature DB >> 10502318

A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas?

A Rosenwald1, G Ott, A K Krumdiek, M H Dreyling, T Katzenberger, J Kalla, S Roth, M M Ott, H K Müller-Hermelink.   

Abstract

Structural aberrations of chromosomal band 13q14 are frequent in B-cell chronic lymphocytic leukemia (B-CLL) and target a putative tumor suppressor gene in the genomic region between the RB1 gene and the genetic marker D13S25. Recently, it has been suggested that alterations of this particular region might also be of relevance for the pathogenesis of mantle cell lymphomas (MCL). We applied dual-color fluorescence in situ hybridization (FISH) using probes for the RB1 and/or D13S25 loci and screened a total of 236 B- and T-cell non-Hodgkin's lymphomas (NHL) for deletions occurring in this genomic region. In MCL, the high rate (12/32; 38%) of hemizygous deletions and especially a deletion pattern similar to B-CLL in four of the cases provide further evidence that a substantial proportion of MCL cases may share a common way of pathogenesis with B-CLL. In other B-cell NHL, the frequency of allelic loss affecting 13q14 was overall low. However, the finding of 13q14 microdeletions in seven cases without detectable alterations of chromosome 13 at G-banding analysis might indicate a possible involvement of this genetic region also for the lymphomagenesis of single cases of B-cell NHL other than B-CLL and MCL. In T-cell NHL, allelic loss at 13q14 was encountered in three of 13 peripheral T-NHL, NOS. Taking into account the very limited cytogenetic data yet available in this entity, our series provides further evidence that 13q14 changes might represent one of the most frequent genetic abnormalities in T-cell NHL. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10502318     DOI: 10.1002/(sici)1098-2264(199911)26:3<210::aid-gcc4>3.0.co;2-j

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.

Authors:  Andreas Zettl; Thomas Rüdiger; Maria-Anette Konrad; Andreas Chott; Ingrid Simonitsch-Klupp; Ruth Sonnen; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

2.  Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma.

Authors:  Andreas Zettl; German Ott; Angela Makulik; Tiemo Katzenberger; Petr Starostik; Thorsten Eichler; Bernhard Puppe; Martin Bentz; Hans Konrad Müller-Hermelink; Andreas Chott
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 3.  Long noncoding RNAs during normal and malignant hematopoiesis.

Authors:  Juan R Alvarez-Dominguez; Wenqian Hu; Austin A Gromatzky; Harvey F Lodish
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

4.  Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region.

Authors:  Aybike Birerdinc; Elizabeth Nohelty; Andrey Marakhonov; Ganiraju Manyam; Ivan Panov; Stephanie Coon; Eugene Nikitin; Mikhail Skoblov; Vikas Chandhoke; Ancha Baranova
Journal:  Tumour Biol       Date:  2009-12-18

5.  Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.

Authors:  George Z Rassidakis; Raymond Lai; Marco Herling; Candy Cromwell; Annette Schmitt-Graeff; L Jeffrey Medeiros
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

6.  Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation.

Authors:  Yvonne Kiefer; Christoph Schulte; Markus Tiemann; Joern Bullerdiek
Journal:  Appl Clin Genet       Date:  2012-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.